Targeted therapy proves effective against aggressive rare blood cancer April 24, 2019 adminMeds newsNo Comment on Targeted therapy proves effective against aggressive rare blood cancer Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.